SciSparc (SPRC) Competitor Comparison
We are evaluating the key criteria listed to compare SciSparc (SPRC) against its competitors in the Biotechnology industry.
Market Capitalization
368 / 368Gross Profits
131 / 278Total Revenue
213 / 300EBITDA
42 / 337Free Cashflow
124 / 352Quick Ratio
327 / 357Earnings per Share
359 / 359Dividend yield
0 / 6Total Cash
345 / 358Performance 3 years
366 / 368Performance 5 years
362 / 368Performance 10 years
342 / 368Linearity 3 years
293 / 368Linearity 5 years
276 / 368Linearity 10 years
266 / 368Total Rank
259 / 368Dividend Rank
6 / 368Valuation Rank
102 / 368Piotroski Rank
47 / 368Muliplier Rank
203 / 368Market Capitalization - SPRC ranking 368 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.